Insider Notice: BANF 5,000 Shares Acquired by Option Exercise, To Be Sold

Rhea-AI Filing Summary

BancFirst Corp (BANF) Form 144 reports a proposed sale of 5,000 shares of common stock acquired by option exercise on 08/13/2025. The broker listed is Charles Schwab & Co and the aggregate market value is reported as $630,800. Shares outstanding are listed at 33,309,310 and the securities are to be sold on Nasdaq GS on the same date. The filing also discloses a prior sale by Fredrick Ford Drummond II of 5,000 shares on 05/28/2025 for gross proceeds of $625,300. The filer attests there is no undisclosed material adverse information related to the issuer.

Insights

Securities Analyst

TL;DR: Routine insider sale: 5,000 BANF shares acquired by option exercise, representing a very small stake versus outstanding shares.

The Form 144 shows a proposed sale of 5,000 shares with an aggregate market value of $630,800. Compared with the reported 33,309,310 shares outstanding, the block represents approximately 0.015% of outstanding shares, indicating limited direct market impact. The filing also notes a prior sale of 5,000 shares on 05/28/2025 for $625,300. This is a standard Rule 144 disclosure documenting an insider sale executed through a broker.

Corporate Governance Expert

TL;DR: Standard compliance filing: seller affirms no material nonpublic information and records acquisition via option exercise.

The notice documents acquisition by option exercise on 08/13/2025 and lists Charles Schwab & Co as the broker. The filer signs the required attestation that they do not possess undisclosed material adverse information. The form also references Rule 10b5-1 trading plans in its attestation language, which is common in such disclosures. No governance irregularities or exemptions are cited in the text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co 3000 Schwab Way Westlake TX 76262	5000	630800.00	33309310	08/13/2025	Nasdaq GS

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/13/2025	Option Exercise	Issuer			5000	08/13/2025	Broker Check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Fredrick Ford Drummond II 100 NORTH BROADWAY AVE OKLAHOMA CITY OK 73102	Common Stock	05/28/2025	5000	625300.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BANF Form 144 disclose?

The filing discloses a proposed sale of 5,000 BANF shares (aggregate market value $630,800) acquired by option exercise on 08/13/2025 to be sold through Charles Schwab.

Who is listed as the broker for the proposed sale in the BANF Form 144?

The broker listed is Charles Schwab & Co with an address at 3000 Schwab Way, Westlake, TX 76262.

How many shares outstanding does the filing list for BANF?

The filing reports 33,309,310 shares outstanding.

Did the filer report any recent prior sales of BANF shares?

Yes. The filing discloses a prior sale by Fredrick Ford Drummond II of 5,000 shares on 05/28/2025 for gross proceeds of $625,300.

What attestation does the seller make in the Form 144?

The seller represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 trading plan language.